Director, President/CEO and Board Chair · Tarsus Pharmaceuticals, Inc. · Common Stock
Side
SELL
Value
$335K
Shares
5,418
Price
$61.81
Executed
Jun 17, 2026
Disclosed
Jun 22, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Jun 17 executedJun 22, 2026 disclosed
TARS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+4 / 15
5 prior trades recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Azamian Bobak R. filed this Form 4 reporting a open-market sale of TARS on Jun 17, 2026. It became public on Jun 22, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President/CEO and Board Chair
Azamian Bobak R.cik:0001827672
Issuer
Tarsus Pharmaceuticals, Inc.cik:0001819790
Revision history · 0
No field has changed since this record was first ingested.
